The Annals Evolution of Clinical Pharmacy | Now Available
home help contact us subscription past issues search current issue
 QUICK SEARCH:   [advanced]


     



Published Online, 27 April 2010, www.theannals.com, DOI 10.1345/aph.1M421.
This Article
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Google Scholar
Right arrow Articles by Ryzner, K. L.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ryzner, K. L.


RESEARCH REPORTS

Evaluation of Aminoglycoside Clearance Using the Modification of Diet in Renal Disease Equation Versus the Cockcroft-Gault Equation as a Marker of Glomerular Filtration Rate(June)

Kristi L Ryzner PharmD BCPS1*

1 at time of writing, PGY1 Pharmacy Practice Resident; now, PGY2 Infectious Diseases Pharmacy Resident, Department of Pharmacy, Boston Medical Center, Atrium Building-H2606, 88 E. Newton St., Boston, MA 02118, fax 617/638-6782, kristi.ryzner@bmc.org

* To whom correspondence should be addressed. E-mail: kristi.ryzner{at}bmc.org.


   Abstract

BACKGROUND: Accurate estimation of kidney function is essential for safe administration of renally cleared drugs. Current practice recommends adjusting renally eliminated drugs according to the Cockcroft-Gault (CG) equation as an estimation of glomerular filtration rate. Few data exist regarding the utility of the Modification of Diet in Renal Disease (MDRD) equation in drug dosing.

OBJECTIVE: To evaluate glomerular filtration rate based on creatinine clearance (CrC1) derived from the MDRD or the CG equation compared with patient-specific CrCl calculated from aminoglycoside peak and trough concentrations.

METHODS: Medical records of patients who received aminoglycoside antibiotics were reviewed over 1 year. Patients who received aminoglycosides via conventional dosing with peak and trough concentrations at steady state were included. Calculations based on standard pharmacokinetic equations were used to estimate CrCl from aminoglycoside serum concentrations. Patient-specific CrCl estimated from aminoglycoside concentrations was compared with estimated CrCl from the CG or MDRD equation.

RESULTS: Fifty-five patients were included in the final analysis. The primary outcome showed concordance between estimated and actual aminoglycoside clearance was 0.53 (95% CI 0.18 to 0.88) for the CG equation and 0.41 (95% CI 0.04 to 0.78) for the MDRD equation. Subgroup analysis also favored CG as a better predictor of CrCl. This signified a stronger correlation between the CG equation and aminoglycoside clearance.

CONCLUSIONS: Compared with the MDRD equation, the CG equation provided better correlation of estimated glomerular filtration rate for aminoglycoside antibiotics. Institutions should continue to use the CG equation as the standard of practice to safely adjust aminoglycoside doses in patients with renal dysfunction.

Key Words: aminoglycoside antibiotics, Cockcroft-Gault equation, drug elimination, glomerular filtration rate, Modification of Diet in Renal Disease equation, renal dosage adjustments.

Reprints: Dr. Ryzner

Conflict of interest: Authors reported none







homecopy help contact us subscription past issues search current issue
Copyright © 2010 by Harvey Whitney Books Company.